Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis

PURPOSE: To assess the evidence for decision making, at the health care and the patient levels, regarding the use of gene expression assays to inform chemotherapy decisions in breast cancer patients with intermediate clinical risk of recurrence. METHODS: Systematic literature searches were performed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Clin Pharmacol
Autors principals: Wallerstedt, Susanna M., Nilsson Ek, Astrid, Olofsson Bagge, Roger, Kovács, Anikó, Strandell, Annika, Linderholm, Barbro
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7419442/
https://ncbi.nlm.nih.gov/pubmed/32504183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-020-02914-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars